Update on skin allergy
暂无分享,去创建一个
[1] A. Raz,et al. Psychosocial factors and chronic spontaneous urticaria: a systematic review , 2013, Allergy.
[2] R. Wood,et al. Challenge-Proven Nonsteroidal Anti-Inflammatory Drug Hypersensitivity in Children , 2014, Pediatrics.
[3] D. Artis,et al. Omalizumab therapy is associated with reduced circulating basophil populations in asthmatic children , 2014, Allergy.
[4] M. Cicardi,et al. Target levels of functional C1‐inhibitor in hereditary angioedema , 2012, Allergy.
[5] T. Shiohara,et al. The dynamics of herpesvirus reactivations during and after severe drug eruptions: their relation to the clinical phenotype and therapeutic outcome , 2014, Allergy.
[6] R. Weaver,et al. Identification and frequency of circulating CD4+ T lymphocytes specific to Benzylpenicillin in healthy donors , 2013, Allergy.
[7] S. Ziegler. The role of thymic stromal lymphopoietin (TSLP) in allergic disorders. , 2010, Current opinion in immunology.
[8] H. Simon,et al. Extracellular DNA traps in allergic, infectious, and autoimmune diseases , 2013, Allergy.
[9] T. Ruzicka,et al. Honey bee (Apis mellifera) venom induces AIM2 inflammasome activation in human keratinocytes , 2012, Allergy.
[10] A. Heratizadeh,et al. Impaired NLRP3 inflammasome expression and function in atopic dermatitis due to Th2 milieu , 2014, Allergy.
[11] H. Moon,et al. Validation of the cephalosporin intradermal skin test for predicting immediate hypersensitivity: a prospective study with drug challenge , 2013, Allergy.
[12] G. Zlabinger,et al. Differential activation of dendritic cells by toll-like receptors causes diverse differentiation of naïve CD4+ T cells from allergic patients , 2014, Allergy.
[13] R. Teshima,et al. Sensitization to acid‐hydrolyzed wheat protein by transdermal administration to BALB/c mice, and comparison with gluten , 2012, Allergy.
[14] T. Klingebiel,et al. Risk of angioedema following invasive or surgical procedures in HAE type I and II – the natural history , 2013, Allergy.
[15] P. Martus,et al. Development and construct validation of the angioedema quality of life questionnaire , 2012, Allergy.
[16] T. Bieber,et al. Off‐label prescriptions for atopic dermatitis in Europe , 2015, Allergy.
[17] T. Zuberbier,et al. The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. , 2014, Allergy.
[18] P. Valent,et al. Mast cell activation syndromes: definition and classification , 2013, Allergy.
[19] M. Mildner,et al. Histamine suppresses epidermal keratinocyte differentiation and impairs skin barrier function in a human skin model , 2012, Allergy.
[20] S. Chirumbolo,et al. Basophil activation test (BAT) in the diagnosis of immediate hypersensitivity reactions to radiocontrast media , 2013, Allergy.
[21] S. Córdoba,et al. Delayed allergic skin reactions due to intralesional meglumine antimoniate therapy for cutaneous leishmaniasis , 2012, Allergy.
[22] I. Heijnen,et al. Skin prick test and basophil reactivity to cetuximab in patients with IgE to alpha‐gal and allergy to red meat , 2014, Allergy.
[23] W. Aberer. Angioedema is not just ‘deep urticaria’ but an entity of its own , 2014, Allergy.
[24] A. Rodrigues,et al. Vitamin A supplementation and BCG vaccination at birth may affect atopy in childhood: long‐term follow‐up of a randomized controlled trial , 2013, Allergy.
[25] S. Scheurer,et al. Epicutaneous immune modulation with Bet v 1 plus R848 suppresses allergic asthma in a murine model , 2014, Allergy.
[26] S. Jariwala,et al. The role of vitamin D in the immunopathogenesis of allergic skin diseases , 2012, Allergy.
[27] Y. Kito,et al. Skin recruitment of monomyeloid precursors involves human herpesvirus‐6 reactivation in drug allergy , 2013, Allergy.
[28] M. Blanca,et al. Diagnostic evaluation of patients with nonimmediate cutaneous hypersensitivity reactions to iodinated contrast media , 2012, Allergy.
[29] M. Taniguchi,et al. Epidemiological link between wheat allergy and exposure to hydrolyzed wheat protein in facial soap , 2014, Allergy.
[30] A. Feilzer,et al. Palladium‐induced Th2 cytokine responses reflect skin test reactivity , 2012, Allergy.
[31] A. Romano,et al. Natural evolution of skin‐test sensitivity in patients with IgE‐mediated hypersensitivity to cephalosporins , 2014, Allergy.
[32] C. Moore,et al. Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir , 2002, The Lancet.
[33] S. Taylor,et al. Challenges in testing genetically modified crops for potential increases in endogenous allergen expression for safety , 2013, Allergy.
[34] C. West,et al. Probiotics in primary prevention of allergic disease – follow‐up at 8–9 years of age , 2013, Allergy.
[35] C. Bindslev‐Jensen,et al. Diagnosis of penicillin allergy revisited: the value of case history, skin testing, specific IgE and prolonged challenge , 2013, Allergy.
[36] B. Marsland,et al. Thymic stromal lymphopoietin plays divergent roles in murine models of atopic and nonatopic airway inflammation , 2014, Allergy.
[37] T. Zuberbier,et al. Up-dosing with bilastine results in improved effectiveness in cold contact urticaria , 2013, Allergy.
[38] S. Weidinger,et al. Atopic dermatitis revisited , 2014, Allergy. European Journal of Allergy and Clinical Immunology.
[39] Jacqueline Adam,et al. Human leukocyte antigens (HLA) associated drug hypersensitivity: consequences of drug binding to HLA , 2012, Allergy.
[40] C. Bindslev‐Jensen,et al. How not to miss autoinflammatory diseases masquerading as urticaria , 2012, Allergy.
[41] A. Wollenberg,et al. Atopic dermatitis, STAT3- and DOCK8-hyper-IgE syndromes differ in IgE-based sensitization pattern. , 2014, Allergy.
[42] H. Simon,et al. Th17 cells and tissue remodeling in atopic and contact dermatitis , 2014, Allergy.
[43] R. Fimmers,et al. TLR2 down‐regulates FcεRI and its transcription factor PU.1 in human Langerhans cells , 2013, Allergy.
[44] T. Bieber. Atopic dermatitis 2.0: from the clinical phenotype to the molecular taxonomy and stratified medicine , 2012, Allergy.
[45] H. Simon,et al. Thymic stromal lymphopoietin stimulates the formation of eosinophil extracellular traps , 2012, Allergy.
[46] R. Asero,et al. Chronic urticaria and coagulation: pathophysiological and clinical aspects , 2014, Allergy.
[47] P. Schmid‐Grendelmeier,et al. EAACI taskforce position paper: evidence for autoimmune urticaria and proposal for defining diagnostic criteria , 2013, Allergy.
[48] T. Zuberbier,et al. Recommendations for the allergy management in the primary care , 2014, Allergy.
[49] M. Blanca,et al. NSAID‐induced urticaria/angioedema does not evolve into chronic urticaria: a 12‐year follow‐up study , 2014, Allergy.
[50] M. Blanca,et al. Contributions of pharmacogenetics and transcriptomics to the understanding of the hypersensitivity drug reactions , 2014, Allergy.
[51] J. Thyssen,et al. The multiple factors affecting the association between atopic dermatitis and contact sensitization , 2014, Allergy.
[52] M. Triggiani,et al. Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group , 2014, Allergy.
[53] J. Hanifin,et al. Systemic therapy of atopic dermatitis , 2000, Clinical and experimental dermatology.
[54] M. Wjst,et al. Low vitamin D serum level is inversely associated with eczema in children and adolescents in Germany , 2013, Allergy.
[55] Yuan-Tsong Chen,et al. HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[56] J. Bernstein,et al. Assessment of rebound and relapse following ecallantide treatment for acute attacks of hereditary angioedema , 2012, Allergy.
[57] H. Williams,et al. Towards global consensus on outcome measures for atopic eczema research: results of the HOME II meeting , 2012, Allergy.
[58] T. Zuberbier,et al. Methods report on the development of the 2013 revision and update of the EAACI/GA2 LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria. , 2014, Allergy.
[59] P. Demoly,et al. Skin test concentrations for systemically administered drugs – an ENDA/EAACI Drug Allergy Interest Group position paper , 2013, Allergy.
[60] L. He,et al. Chronic urticaria in Chinese population: a hospital‐based multicenter epidemiological study , 2014, Allergy.
[61] A. Kong,et al. Eczema phenotypes are associated with multiple vitamin D pathway genes in Chinese children , 2014, Allergy.
[62] W. Aberer,et al. Open‐label, multicenter study of self‐administered icatibant for attacks of hereditary angioedema , 2014, Allergy.
[63] A. Goossens,et al. Systemic contact dermatitis to corticosteroids , 2012, Allergy.
[64] H. Saito,et al. Cell type‐dependent effects of corticosteroid on periostin production by primary human tissue cells , 2013, Allergy.
[65] R. Moncada,et al. Early skin testing is effective for diagnosis of hypersensitivity reactions occurring during anesthesia , 2013, Allergy.
[66] J. Li,et al. Skin thymic stromal lymphopoietin promotes airway sensitization to inhalant house dust mites leading to allergic asthma in mice , 2012, Allergy.
[67] L. Schnitzler,et al. Schnitzler's syndrome: diagnosis, treatment, and follow‐up , 2013, Allergy.
[68] H. Kita,et al. Group 2 innate lymphoid cells and CD4+ T cells cooperate to mediate type 2 immune response in mice , 2014, Allergy.
[69] A. Romano,et al. Allergy to betalactams and nucleotide‐binding oligomerization domain (NOD) gene polymorphisms , 2013, Allergy.
[70] T. Bieber,et al. Dupilumab treatment in adults with moderate-to-severe atopic dermatitis. , 2014, The New England journal of medicine.
[71] C. Flohr,et al. New approaches to the prevention of childhood atopic dermatitis , 2014, Allergy.
[72] R Fimmers,et al. Characterization of different courses of atopic dermatitis in adolescent and adult patients , 2013, Allergy.
[73] S. Jee,et al. Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions , 2006, Pharmacogenetics and genomics.
[74] M. Maurer,et al. Platelet‐activating factor (PAF) induces wheal and flare skin reactions independent of mast cell degranulation , 2013, Allergy.
[75] M. Akiyama,et al. Comprehensive screening for a complete set of Japanese‐population‐specific filaggrin gene mutations , 2014, Allergy.
[76] P. Demoly,et al. Desensitization in delayed drug hypersensitivity reactions – an EAACI position paper of the Drug Allergy Interest Group , 2013, Allergy.
[77] B. Niggemann,et al. Peanut allergen in house dust of eating area and bed – a risk factor for peanut sensitization? , 2013, Allergy.
[78] C. Hawrylowicz,et al. Vitamin D deficiency induces Th2 skewing and eosinophilia in neonatal allergic airways disease , 2014, Allergy.
[79] A. Dubois,et al. Where to prick the apple for skin testing? , 2013, Allergy.
[80] P. Demoly,et al. Severe drug‐induced anaphylaxis: analysis of 333 cases recorded by the Allergy Vigilance Network from 2002 to 2010 , 2013, Allergy.
[81] S. Nakae,et al. Interleukin‐33 in allergy , 2012, Allergy.
[82] A. Romano,et al. Absence of cross‐reactivity to carbapenems in patients with delayed hypersensitivity to penicillins , 2013, Allergy.
[83] R. Heddle,et al. Randomized controlled trial of fish oil supplementation in pregnancy on childhood allergies , 2013, Allergy.
[84] P. Schmid‐Grendelmeier,et al. Repeat treatment with icatibant for multiple hereditary angioedema attacks: FAST‐2 open‐label study , 2013, Allergy.
[85] T. Hiragun,et al. Prognosis of chronic spontaneous urticaria in 117 patients not controlled by a standard dose of antihistamine , 2013, Allergy.
[86] C. Flohr,et al. New insights into the epidemiology of childhood atopic dermatitis , 2014, Allergy.
[87] A. Romano,et al. Biological and genetic determinants of atopy are predictors of immediate‐type allergy to betalactams, in Spain , 2012, Allergy.
[88] N. Novak,et al. Immunology of atopic eczema: overcoming the Th1/Th2 paradigm , 2013, Allergy.
[89] I. Barlan,et al. Vitamin D as an adjunct to subcutaneous allergen immunotherapy in asthmatic children sensitized to house dust mite , 2014, Allergy.
[90] J. Bousquet,et al. Persistency of response to omalizumab therapy in severe allergic (IgE‐mediated) asthma , 2011, Allergy.
[91] S. Simoens,et al. Economic burden of inadequate management of allergic diseases in the European Union: a GA2LEN review , 2014, Allergy.
[92] T. Illig,et al. Increased efficacy of omalizumab in atopic dermatitis patients with wild‐type filaggrin status and higher serum levels of phosphatidylcholines , 2014, Allergy.
[93] J. Dalphin,et al. Usefulness of omalizumab in ten patients with severe occupational asthma , 2013, Allergy.
[94] D. Lipsker,et al. Unexplained recurrent fever: when is autoinflammation the explanation? , 2013, Allergy.
[95] P. Demoly,et al. International Consensus on drug allergy , 2014, Allergy.
[96] M. Blanca,et al. Diagnosis of immediate hypersensitivity reactions to radiocontrast media , 2013, Allergy.
[97] S. Akira,et al. Epicutaneously applied Der p 2 induces a strong TH2-biased antibody response in C57BL/6 mice, independent of functional TLR4 , 2014, Allergy.
[98] K. Obtulowicz,et al. Recombinant human C1 inhibitor for the prophylaxis of hereditary angioedema attacks: a pilot study , 2013, Allergy.
[99] M. Longnecker,et al. Triclosan exposure and allergic sensitization in Norwegian children , 2012, Allergy.
[100] J. Stone,et al. Prevalence of atopy, eosinophilia, and IgE elevation in IgG4‐related disease , 2014, Allergy.
[101] M. Maurer,et al. Practical algorithm for diagnosing patients with recurrent wheals or angioedema , 2013, Allergy.
[102] E. Nizankowska-Mogilnicka,et al. Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti‐inflammatory drugs , 2013, Allergy.
[103] R. Zubarev,et al. Protein biomarkers in vernix with potential to predict the development of atopic eczema in early childhood , 2013, Allergy.
[104] H. Farkas,et al. Short‐term prophylaxis in hereditary angioedema due to deficiency of the C1‐inhibitor – a long‐term survey , 2012, Allergy.
[105] A. Bircher,et al. Nonirritant intradermal skin test concentrations of ciprofloxacin, clarithromycin, and rifampicin , 2012, Allergy.
[106] M. Kowalski,et al. A phenotype‐based classification of NSAIDs hypersensitivity: new patients, new challenges , 2014, Allergy. European Journal of Allergy and Clinical Immunology.
[107] T. Bieber,et al. Atopic dermatitis: a candidate for disease‐modifying strategy , 2012, Allergy.
[108] M. Triggiani,et al. Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on Mastocytosis , 2014, Allergy.
[109] K. Ahn,et al. IgE‐mediated anaphylaxis and allergic reactions to idursulfase in patients with Hunter syndrome , 2013, Allergy.
[110] M. P. Berges-Gimeno,et al. Hypersensitivity and desensitization to antineoplastic agents: outcomes of 189 procedures with a new short protocol and novel diagnostic tools assessment , 2013, Allergy.
[111] N. Novak,et al. Atopic dermatitis – from new pathophysiologic insights to individualized therapy , 2011, Allergy.
[112] M. Triggiani,et al. Evidence‐based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group , 2012, Allergy.
[113] C. Akdis,et al. FcεRI stimulation promotes the differentiation of histamine receptor 1‐expressing inflammatory macrophages , 2013, Allergy.
[114] H. Zar,et al. International consensus on (ICON) pediatric asthma , 2012, Allergy.
[115] C J Lodge,et al. CD14 polymorphisms, microbial exposure and allergic diseases: a systematic review of gene–environment interactions , 2014, Allergy.
[116] M. Triggiani,et al. Icatibant treatment for acquired C1‐inhibitor deficiency: a real‐world observational study , 2012, Allergy.
[117] P. Valent,et al. The KIT D816V allele burden predicts survival in patients with mastocytosis and correlates with the WHO type of the disease , 2014, Allergy.
[118] O. Peleg,et al. Medical clowns ease anxiety and pain perceived by children undergoing allergy prick skin tests , 2014, Allergy.
[119] D. Moneret-vautrin,et al. Epidemiology of life‐threatening and lethal anaphylaxis: a review , 2005, Allergy.
[120] A. Órfão,et al. Contribution of highly sensitive diagnostic methods to the diagnosis of systemic mastocytosis in the absence of skin lesions , 2012, Allergy.
[121] D. Naisbitt,et al. Multiple drug hypersensitivity: normal Treg cell function but enhanced in vivo activation of drug‐specific T cells , 2012, Allergy.
[122] J. Schmitt,et al. Nonallergic comorbidities of atopic eczema: an overview of systematic reviews , 2014, Allergy.
[123] T. Zuberbier,et al. Efficacy and safety of the interleukin‐1 antagonist rilonacept in Schnitzler syndrome: an open‐label study , 2012, Allergy.
[124] M. Maurer,et al. Interleukin‐31 does not induce immediate itch in atopic dermatitis patients and healthy controls after skin challenge , 2014, Allergy.
[125] W. Pichler,et al. NKp46+ cells express granulysin in multiple cutaneous adverse drug reactions , 2011, Allergy.
[126] A. Lowe,et al. Atopic dermatitis and the atopic march revisited , 2014, Allergy.
[127] N. Hirasawa,et al. The antagonism of histamine H1 and H4 receptors ameliorates chronic allergic dermatitis via anti‐pruritic and anti‐inflammatory effects in NC/Nga mice , 2012, Allergy.
[128] Peter Natesan Pushparaj,et al. Interleukin-33 amplifies IgE synthesis and triggers mast cell degranulation via interleukin-4 in naïve mice1 , 2012, Allergy.